ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #6,300Gold OA

Immunity Inflammation and Disease

Abbreviation (ISO):IMMUN INFLAMM DIS
•
Identifier (ISSN):2050-4527(Print)
•
Publisher:Wiley-Blackwell
Clarivate IF (2026)
3.5↑ +0.8
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Immunity Inflammation and Disease

WoS Q2
12452.520202.2420212.4920223.220233.120242.720253.52026
Annual Impact Factor Metric
Current (2026):3.5
Scopus SJR & RankScopus Q2
0.851
#6,300

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
43

43 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate3.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
172articles/year
100% Gold OA•87.97% Original Research

Aims & Scope

Immunity, Inflammation and Disease is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research across the broad field of immunology. Immunity, Inflammation and Disease gives rapid consideration to papers in all areas of clinical and basic research. The journal is indexed in Medline and the Science Citation Index Expanded (part of Web of Science), among others. It welcomes original work that enhances the understanding of immunology in areas including: • cellular and molecular immunology • clinical immunology • allergy • immunochemistry • immunogenetics • immune signalling • immune development • imaging • mathematical modelling • autoimmunity • transplantation immunology • cancer immunology

Topics Covered (Recognized by AI)
Medicine86.5%Biology85.7%Immunology77.7%Internal medicine75.6%Genetics74.3%Chemistry61.1%Biochemistry58.4%Pathology47.7%Immune system38.7%Gene28.2%Antibody24.1%Surgery24%Endocrinology23.9%Antigen22.4%Cell biology22%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q2
Rank89/183
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q3
Rank110/183
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.5
Articles / Year186
Total Citations50
2025
IF2.7
Articles / Year224
Total Citations586
2024
IF3.1
Articles / Year369
Total Citations2,446
2023
IF3.2
Articles / Year362
Total Citations3,859
2022
IF2.493
Articles / Year176
Total Citations1,867

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,300Scopus Q2SCImago Profile
Scopus Coverage:2013-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q2
0.851

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.53

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,140 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,949
3-Year Documents855
Citable Documents839

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ2
Immunology and AllergyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Immunity Inflammation and Disease (abbr: IMMUN INFLAMM DIS, ISSN: 2050-4527) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wiley-Blackwell in England. The periodical holds a Journal Impact Factor (JIF) of 3.50, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.851 (Q2), an H-index of 43.

The journal enforces rigorous peer evaluation with an annual output of approximately 172 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,140 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Wiley-Blackwell
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 7bc84ae7-cfff-4141-ba28-09e568a5bb84
Database Updated: 2026-10-01